Novel Immunotherapies Oncology needs
Vaccine Adjuvants Innate Immune Lassa Fever

Who We Are

Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life science technologies that address unmet patient needs. We have leveraged our expertise in immunology to advance a focused pipeline of investigational drugs in oncology, neuroscience and virology.

We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta has established strategic partnerships with leading science-driven organizations to accelerate the development of our pipeline of novel immunotherapies.

More About Kineta